Structure Therapeutics (GPCR) Stock Price & Financial Analysis
Structure Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Structure Therapeutics
What is the current stock price for GPCR?
As of the latest trading session, GPCR stock trades at $53.48. The 52-week range is $13.22–$94.90, with a day range of $48.00–$55.75.
What is the P/E ratio for GPCR?
The P/E ratio (Price-to-Earnings) for GPCR is shown in the Key Statistics section. This valuation metric helps compare Structure Therapeutics Inc. to industry peers.
Does GPCR pay dividends?
Structure Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for GPCR?
Based on 11 analysts, the consensus for GPCR is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of GPCR?
Structure Therapeutics's market capitalization is $3.17B, classifying it as a mid-cap company. Structure Therapeutics operates in the Healthcare sector within the Biotechnology industry.